tiprankstipranks
Buy Rating Affirmed for Healthequity Amid Strong Revenue Outlook and Growth Potential
PremiumRatingsBuy Rating Affirmed for Healthequity Amid Strong Revenue Outlook and Growth Potential
7d ago
Healthequity: Strong Revenue Growth and Attractive Valuation Despite Earnings Miss
Premium
Ratings
Healthequity: Strong Revenue Growth and Attractive Valuation Despite Earnings Miss
7d ago
HealthEquity Stock (NASDAQ:HQY) Tumbles 17% on Earnings Miss as Analyst Trims Outlook
Premium
Market News
HealthEquity Stock (NASDAQ:HQY) Tumbles 17% on Earnings Miss as Analyst Trims Outlook
7d ago
Healthequity (HQY) Fraud Prevention Costs Stall Earnings Yet Analysts Remain Bullish
PremiumMarket NewsHealthequity (HQY) Fraud Prevention Costs Stall Earnings Yet Analysts Remain Bullish
7d ago
Closing Bell Movers: HealthEquity down 13% on Q4 miss and guidance
Premium
The Fly
Closing Bell Movers: HealthEquity down 13% on Q4 miss and guidance
7d ago
HealthEquity sees FY26 EPS $3.57-$3.74, consensus $3.76
Premium
The Fly
HealthEquity sees FY26 EPS $3.57-$3.74, consensus $3.76
7d ago
Promising Outlook for Healthequity Amid Potential HSA Legislative Changes and Strong Fundamentals
PremiumRatingsPromising Outlook for Healthequity Amid Potential HSA Legislative Changes and Strong Fundamentals
13d ago
HealthEquity price target raised to $125 from $110 at Wells Fargo
Premium
The Fly
HealthEquity price target raised to $125 from $110 at Wells Fargo
28d ago
HealthEquity price target raised to $120 from $105 at Raymond James
Premium
The Fly
HealthEquity price target raised to $120 from $105 at Raymond James
29d ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100